Algernon Logo 1.png
Algernon Pharmaceuticals Launches Pancreatic Cancer Clinical Research Program with Ifenprodil
June 03, 2021 07:00 ET | Algernon Pharmaceuticals
VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) announces it has initiated a new...